Covered recipient · General Payments record
FLOYD E TRINIDAD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$463.28
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $268.92 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $61.03 | 3 |
| Novo Nordisk AS | $51.95 | 3 |
| Lilly USA, LLC | $37.83 | 2 |
| ABBVIE INC. | $35.40 | 2 |
| Edwards Lifesciences Corporation | $25.39 | 1 |
| PFIZER INC. | $23.72 | 1 |
| Astellas Pharma US Inc | $19.92 | 1 |
| Exact Sciences Corporation | $13.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.92 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243590 | CMS |
| ABBVIE INC. | $18.48 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106243592 | CMS |
| Astellas Pharma US Inc | $19.92 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139434844 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.87 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105613461 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.23 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105743862 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.93 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105583172 | CMS |
| Edwards Lifesciences Corporation | $25.39 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138866619 | CMS |
| Exact Sciences Corporation | $13.68 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114935072 | CMS |
| Lilly USA, LLC | $19.33 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134982304 | CMS |
| Lilly USA, LLC | $18.50 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134976464 | CMS |
| Novo Nordisk Inc | $18.59 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096943239 | CMS |
| Novo Nordisk Inc | $14.99 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096839077 | CMS |
| Novo Nordisk Inc | $18.37 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096653984 | CMS |
| PFIZER INC. | $23.72 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131077933 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.